Another study on adult Ph-like ALL patients found that CRLF2 overexpression is associated with poor prognosis, with a 5-year survival rate of less than 20% (Roberts et al., 2014a; Jain et al., 2017). This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.